Arrowhead Pharmaceuticals
About:
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Website: http://arrowheadpharma.com/
Twitter/X: ArrowheadPharma
Top Investors: RA Capital Management, Sixth Street, OrbiMed, Silence Therapeutics, York Capital Management
Description:
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
$1.3B
$100M to $500M
Pasadena, California, United States
1989-01-01
info(AT)arrowres.com
R. Bruce Stewart
501-1000
2024-08-08
Public
© 2025 bioDAO.ai